Search


Current filters:





Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 23 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2010Primary radiotherapy in progressive optic nerve sheath meningiomas: a long-term follow-up studySaeed, P.; Blank, L.; Selva-Nayagam, D.; Wolbers, J.; Nowak, P.; Geskus, R.; Weis, E.; Mourits, M.; Rootman, J.
2010Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)Hughes, T.; Hochhaus, A.; Branford, S.; Muller, M.; Kaeda, J.; Foroni, L.; Druker, B.; Guilhot, F.; Larson, R.; O'Brien, S.; Rudoltz, M.; Mone, M.; Wehrle, E.; Modur, V.; Goldman, J.; Radich, J.
2010The psychiatric sequelae of traumatic injuryBryant, R.; O'Donnell, M.; Creamer, M.; McFarlane, A.; Clark, C.; Silove, D.
2010The cost-effectiveness of point of care testing in a general practice setting: Results from a randomised controlled trialLaurence, C.; Moss, J.; Briggs, N.; Beilby, J.
2010Appropriate use of non-prescription ibuprofen: A survey of patients' perceptions and understandingNgo, S.; Stupans, I.; Leong, W.; Osman, M.
2010Seeking treatment for symptomatic malaria in Papua New GuineaDavy, C.; Sicuri, E.; Ome, M.; Lawrence-Wood, E.; Siba, P.; Warvi, G.; Mueller, I.; Conteh, L.
2010Phase III, randomized, open-label study of daily Imatinib Mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: Tyrosine Kinase Inhibitor Optimization and Selectivity StudyCortes, A.; Baccarani, M.; Guilhot, F.; Druker, B.; Branford, S.; Kim, D.; Pane, F.; Pasquini, R.; Goldberg, S.; Kalaycio, M.; Moiraghi, B.; Rowe, J.; Tothova, E.; de Souza, C.; Rudoltz, M.; Yu, R.; Krahnke, T.; Kantarjian, H.; Radich, J.; Hughes, T.
2010Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastasesEndo-Munoz, L.; Cumming, A.; Rickwood, D.; Wilson, D.; Cueva, C.; Ng, C.; Strutton, G.; Cassady, A.; Evdokiou, A.; Sommerville, S.; Dickinson, I.; Guminski, A.; Saunders, N.
2010Determinants of self-reported medicine underuse due to cost: A comparison of seven countriesKemp, A.; Roughead, E.; Preen, D.; Glover, J.; Semmens, J.
2010The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I)Faries, M.; Thompson, J.; Cochran, A.; Elashoff, R.; Glass, E.; Mozzillo, N.; Nieweg, O.; Roses, D.; Hoekstra, H.; Karakousis, C.; Reintgen, D.; Coventry, B.; Wang, H.; Morton, D.